Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate stays among the most vital tools in modern-day anaesthesia and intense discomfort management throughout the United Kingdom. As a potent synthetic opioid, its function in the National Health Service (NHS) and personal surgical sectors is reputable, mostly due to its rapid onset of action and cardiovascular stability. This blog site post provides a detailed summary of fentanyl citrate injection formulations offered in the UK, their clinical signs, regulative landscape, and administration procedures.
What is Fentanyl Citrate?
Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. It was first synthesized in 1960 and quickly became a foundation of perioperative care. In terms of potency, fentanyl is approximately 50 to 100 times more potent than morphine. Its high lipophilicity allows it to cross the blood-brain barrier rapidly, causing a nearly instant analgesic result when administered intravenously.
In the UK, fentanyl citrate is primarily used through the parenteral path (injection) for both sedative and analgesic functions. It works primarily by binding to the mu-opioid receptors in the main anxious system, changing the understanding of pain and the emotional action to it.
Scientific Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is shown for numerous particular scientific scenarios:
- Analgesic Action: Used during brief personnel procedures and in the healing space.
- Analgesic Supplement: Used during the induction and maintenance of inhalation anaesthesia.
- Neuroleptanalgesia: Often used in combination with a neuroleptic (such as droperidol) to achieve a state of quiescence and decreased awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
- Pre-medication: To offer sedation and analgesia before the induction of basic anaesthesia.
Readily Available Formulations and Strengths in the UK
The UK market offers a number of formulations of fentanyl citrate, developed to satisfy the varying needs of surgical and emergency situation departments. These are typically provided as clear, colourless services for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Common Packaging | Maker Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Pack of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Pack of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Load of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU usage) |
Note: While 50 mcg/ml is the basic concentration, specialised formulations for epidural or intrathecal use might in some cases be prepared by hospital pharmacies under specific protocols.
Pharmacokinetics and Pharmacodynamics
Understanding how the body processes fentanyl is crucial for safe administration.
- Beginning of Action: When administered intravenously, the result begins almost right away, though the optimum analgesic effect might take 3 to 5 minutes.
- Duration: A single intravenous dose of 100 micrograms typically lasts for 30 to 60 minutes.
- Metabolism: Fentanyl is primarily metabolised in the liver by means of the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dosage is excreted in the urine within 24 hours, mostly as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly controlled and usually performed by anaesthetists or trained professionals in regulated environments.
Dose Guidelines
Dosage needs to be horizontal and individualised based on the client's age, weight, physical status, underlying pathological condition, usage of other drugs, and the kind of surgical treatment.
- Low Dose (2 mcg/kg): Useful for minor surgical treatments.
- Moderate Dose (2-- 20 mcg/kg): Used when surgery is more invasive; requires breathing monitoring.
- High Dose (20-- 50 mcg/kg): Used throughout "worry-free" major surgical treatments (e.g., open-heart surgical treatment) to safeguard the myocardium from the metabolic needs of tension.
Routes of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer treatments or in the ICU.
- Intramuscular (IM): Less typical, however utilized for pre-medication in particular scenarios.
Regulative Status and Safety
In the United Kingdom, Fentanyl is categorized under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is categorized as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be kept in a locked controlled drug cupboard.
- Record Keeping: Every administration must be recorded in a Controlled Drugs Register (CDR).
- Damage: Surplus or ended fentanyl should be denatured and witnessed by authorised personnel.
Adverse Effects and Adverse Reactions
While extremely effective, fentanyl citrate brings a risk of considerable negative effects.
- Respiratory Depression: The most serious side effect, which can lead to respiratory arrest if not monitored.
- Bradychardia: Often managed with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High dosages can make ventilation challenging, requiring making use of neuromuscular blocking agents.
- Nausea and Vomiting: Common in the postoperative duration.
- Hypotension: Although more steady than morphine, it can still occur, especially in hypovolaemic patients.
Comparison with Other Opioids
Clinicians typically select fentanyl over other opioids due to its particular pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Feature | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Start | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Duration of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Negligible | Considerable | Minimal |
| Main Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Often Asked Questions (FAQ)
1. Is fentanyl citrate injection the same as the fentanyl patches?
No. While Fentanyl Analogs UK contain the very same active drug, the injection is for immediate, severe use in surgical or emergency situation settings. Patches (transdermal delivery) are created for chronic, long-lasting discomfort management and release the medication gradually over 72 hours.
2. Can fentanyl citrate be used for kids in the UK?
Yes, it is frequently utilized in paediatric anaesthesia. However, the dose should be strictly calculated based upon the kid's weight, and they must be kept track of carefully for breathing depression.
3. What is the antagonist for fentanyl?
Naloxone is the specific pharmacological antagonist used to reverse the impacts of fentanyl, including respiratory anxiety. In Fentanyl Citrate UK , naloxone must always be readily available wherever fentanyl is administered.
4. Why is it utilized over morphine in heart surgery?
Fentanyl is preferred in heart surgical treatment since it does not trigger the release of histamine, which can result in vasodilation and hypotension. It offers cardiovascular stability even at high doses.
5. What are the storage requirements?
Fentanyl citrate injection ought to be saved below 25 ° C and safeguarded from light. As a Schedule 2 drug, it needs to be kept in a lawfully certified CD cupboard.
Fentanyl citrate injection formulas are important parts of the UK's medical toolkit for managing perioperative pain and assisting in complicated surgical treatments. Its high strength and fast onset deal unequaled precision for anaesthetists, provided that strenuous monitoring and regulative standards are kept. By comprehending the different concentrations and the rigorous protocols surrounding its usage, healthcare specialists guarantee that this effective medication stays both safe and effective for clients across the nation.
Disclaimer: This short article is for informative purposes just and does not make up medical advice. Healthcare specialists should always describe the Summary of Product Characteristics (SmPC) and current BNF standards for the most current recommending information.
